Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder

Journal of Urology

Volumn 159, Issue 2, 1998, Pages 394-398

  Stampfer, David S ^a   Carpinito, Gennaro A ^b   Rodriguez Villanueva, Julio ^b   Willsey, Lance W ^b   Dinney, Colin P ^b   Grossman, H Barton ^b   Fritsche, Herbert A ^b   McDougal, W Scott ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Bladder; Bladder neoplasms; Carcinoma, transitional cell; Nuclear matrix; Tumor markers, biological

Indexed keywords

MATRIX PROTEIN; NUCLEAR MATRIX PROTEIN 22; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CLINICAL TRIAL; CYSTOSCOPY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0031965140     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63930-2     Document Type: Article

References (14)

1. Boring, C. C., Squires, T. S. and Tong, T.: Cancer statistics, 1995. CA, 45: 8, 1995.
2. Abel, P. D.: Prognostic indices in transitional cell carcinoma of the bladder. Brit. J. Urol., 62: 103, 1988.
3. Sarosdy, M. F., De Vere White, R. W., Soloway, M. S., Sheinfeld, J., Hudson, M. A., Schellhammer, P. F., Jarowenko, M. V., Adams, G. and Blumenstein, B. A.: Results of a multicenter trial using BTA test to monitor for and diagnose recurrent bladder cancer. J. Urol., 154: 379, 1995.
4. Badalament, R. A., Hermansen, D. K., Kimmel, M., Gay, H., Herr, H. W., Fair, W. R., Whitmore, W. F., Jr. and Melamed, M. R.: The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer, 60: 1423, 1987.
5. Soloway, M. S., Briggman, J. V., Carpinito, G. A., Chodak, G. W., Church, P. A., Lamm, D. L., Lange, P., Messing, E., Pasciak, R. M., Reservitz, G. B., Rukstalis, D. B., Sarosdy, M. F., Stadler, W. M., Thiel, R. P. and Hayden, C. L.: Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J. Urol., 156: 363, 1996.
6. Carpinito, G. A., Stadler, W. M., Briggman, J. V., Chodak, G. W., Church, P. A., Lamm, D. L., Lange, P. H., Messing, E. M., Pasciak, R. M., Reservitz, G. B., Ross, R. N., Rukstalis, D. B., Sarosdy, M. F., Soloway, M. S., Thiel, R. P., Vogelzang, N. and Hayden, C. L.: Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract. J. Urol., 156: 1280, 1996.
7. Korman, H. J., Peabody, J. O., Cerny, J. C., Farah, R. N., Yao, J. and Raz, A.: Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder. J. Urol., 155: 347, 1996.
8. Schmetter, B. S., Habicht, K. K., Lamm, D. L., Morales, A., Grossman, H. B., Bander, N., Hanna, M. G. and Butman, B. T.: Results of a multicenter trial evaluation of Aura-Tek FDP: An aid in the management of bladder cancer patients. J. Urol., part 2, 155: 492A, abstract 725, 1996.
9. Gilbert, H. A., Logan, J. L., Kagan, A. R., Friedman, H. A., Cove, J. K., Fox, M., Muldoon, T. M., Lonni, Y. W., Rowe, J. H., Cooper, J. F., Nussbaum, H., Chan, P., Rao, A. and Starr, A.: The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histological grading. J. Urol., 119: 488, 1978.
10. Althausen, A. P., Prout, G. R., Jr. and Daly, J. J.: Noninvasive papillary carcinoma of the bladder associated with carcinoma in situ. J. Urol., 116: 575, 1976.
11. Lutzeyer, W., Ruebben, H. and Dahm, H.: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J. Urol., 127: 250, 1982.
12. a grades 1 and 2): the importance of recurrence pattern following initial resection. J. Urol., 135: 920, 1986.
13. Heney, N. M., Nocks, B. N., Daly, J. J., Prout, G. R., Jr., Newall, J. B., Griffin, P. P., Perrone, T. L. and Szyfelbein, W. A.: Ta and T1 bladder cancer: location, recurrence and progression. Brit. J. Urol., 54: 152, 1982.
14. Kilbridge, K. L., Kuntz, K. M., Kagan, A. R., Loughlin, K. R., Wald, J., Weinstein, M. C., Kantoff, P. and Weeks, J. C.: Is frequent followup cystosopy cost-effective in superficial transitional cell carcinoma of the bladder? J. Urol. 155: 1406, 1996.